Condition
Acute Myeloid Leukemia
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 16 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
16 shownCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionNCT05334069 · 2022-08-18
RECRUITINGPET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9NCT05212103 · 2023-09-01
ENROLLING_BY_INVITATIONCord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic CancersNCT04083170 · 2022-10-06
TERMINATEDA Study to Investigate 14C-bemcentinib in Healthy Male SubjectsNCT06469138 · 2022-08-02
COMPLETEDThe Registry of Oncology Outcomes Associated With Testing and TreatmentNCT04028479 · 2021-05-05
COMPLETEDA Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.NCT04671693 · 2020-12-24
ACTIVE_NOT_RECRUITINGNational Cancer Institute "Cancer Moonshot Biobank"NCT04314401 · 2020-11-11
ACTIVE_NOT_RECRUITINGSARS-CoV-2 Donor-Recipient Immunity TransferNCT04666025 · 2020-09-23
COMPLETEDUmbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaNCT03096782 · 2017-10-13
COMPLETEDHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerNCT03154190 · 2017-08-08
COMPLETEDStudy on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML PatientsNCT02856178 · 2017-04-20
WITHDRAWNStudy of ProTmune for Allogeneic HCT in Adult Patients With Hematologic MalignanciesNCT02743351 · 2016-12-20
COMPLETEDA Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced MalignanciesNCT02498665 · 2015-11-01
COMPLETEDCINC424A2X01B Rollover ProtocolNCT02386800 · 2015-03-05
ACTIVE_NOT_RECRUITINGBioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesNCT02223052 · 2014-10-27
COMPLETEDNebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary AspergillosisNCT00391014 · 2006-01-01
COMPLETEDCommon interventions
Biospecimen CollectionPROCEDURE3CyclophosphamideDRUG2FludarabineDRUG2Questionnaire AdministrationOTHER2Total-Body IrradiationRADIATION2Umbilical Cord Blood TransplantationPROCEDURE2Anti-Thymocyte GlobulinBIOLOGICAL1BemcentinibDRUG1Best PracticeOTHER1Biomarker Testing (L)DIAGNOSTIC_TEST1BusulfanDRUG1CaspofunginDRUG1CC-486DRUG1ClofarabineDRUG1Computed TomographyPROCEDURE1Control ArmBIOLOGICAL1Diagnostic Laboratory Biomarker AnalysisOTHER1DilanubicelBIOLOGICAL1DSP-7888 Dosing EmulsionDRUG1Electronic Health Record ReviewOTHER1F901318DRUG1Filgrastim-sndzBIOLOGICAL1Laboratory Biomarker AnalysisOTHER1liposomal Amphotericine BDRUG1Magnetic Resonance ImagingPROCEDURE1
Leading sponsors
Alliance for Clinical Trials in Oncology
1
BerGenBio ASA
1
Celgene
1
Centre Leon Berard
1
City of Hope Medical Center
1
F2G Ltd
1
Fate Therapeutics
1
Fred Hutchinson Cancer Center
1
M.D. Anderson Cancer Center
1
National Cancer Institute (NCI)
1
Novartis Pharmaceuticals
1
PETHEMA Foundation
1
Stanford University
1
Sumitomo Pharma America, Inc.
1
Taproot Health
1
Trial status mix
COMPLETED9
ACTIVE_NOT_RECRUITING3
ENROLLING_BY_INVITATION1
RECRUITING1
TERMINATED1
WITHDRAWN1
Phase mix
PHASE15
PHASE25
NA2
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.